Dr. Slepnev is Chief Scientific Officer and co-founder of Curative. Dr. Slepnev previously led teams that have built and launched 10 FDA-cleared diagnostic products in the infectious disease space. He led molecular R&D at Meridian Biosciences (public Dx company), which developed 9 FDA cleared tests + 13 CE marked tests. He is a co-founder of Primera Dx, which raised more than $50M and sold to Qiagen.